We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+14.09%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+305.76%
AUM
$79.1B
AUM Growth
+$7.99B
(+11%)
Cap. Flow
-$5.86B
Cap. Flow
% of AUM
-7.4%
Top 10 Holdings %
Top 10 Hldgs %
22.63%
Holding
2,061
New
445
Increased
504
Reduced
465
Closed
231
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sysco
SYY
|
+$273M |
| 2 |
Waste Management
WM
|
+$168M |
| 3 |
Lowe's Companies
LOW
|
+$160M |
| 4 |
PNC Financial Services
PNC
|
+$154M |
| 5 |
Unilever
UL
|
+$122M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$548M |
| 2 |
Apple
AAPL
|
+$372M |
| 3 |
CSX Corp
CSX
|
+$369M |
| 4 |
Infosys
INFY
|
+$238M |
| 5 |
Kimberly-Clark
KMB
|
+$235M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.16% |
| 2 | Healthcare | 14.65% |
| 3 | Financials | 13.08% |
| 4 | Industrials | 9.66% |
| 5 | Consumer Discretionary | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
CryoPort
CYRX
$755M
| $2.28M | ﹤0.01% |
+51,953
| New | +$2.47M |
|
627
MYR Group
MYRG
$5.29B
| $2.25M | ﹤0.01% |
37,526
+33,259
| +779% | +$1.65M |
|
628
Lam Research
LRCX
$388B
| $2.25M | ﹤0.01% |
47,610
-54,910
| -54% | -$2.31M |
|
629
RH
RH
$3.66B
| $2.24M | ﹤0.01% |
+5,002
| New | +$2.06M |
|
|
SAVE
630
DELISTED
Spirit Airlines, Inc.
SAVE
| $2.24M | ﹤0.01% |
91,555
+88,967
| +3,438% | +$1.84M |
|
|
XIFR
631
XPLR Infrastructure LP
XIFR
$1.09B
| $2.23M | ﹤0.01% |
+33,265
| New | +$2.14M |
|
|
CMD
632
DELISTED
Cantel Medical Corporation
CMD
| $2.23M | ﹤0.01% |
+28,259
| New | +$1.66M |
|
633
FormFactor
FORM
$9.26B
| $2.22M | ﹤0.01% |
51,627
-25,228
| -33% | -$911K |
|
|
BKI
634
DELISTED
Black Knight, Inc. Common Stock
BKI
| $2.21M | ﹤0.01% |
25,058
-28,050
| -53% | -$2.55M |
|
635
Copa Holdings
CPA
$5.78B
| $2.19M | ﹤0.01% |
+28,395
| New | +$1.89M |
|
636
iShares Core MSCI Europe ETF
IEUR
$9.15B
| $2.18M | ﹤0.01% |
42,580
| – | – |
|
|
LSXMA
637
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $2.16M | ﹤0.01% |
+68,043
| New | +$1.97M |
|
638
Virtu Financial
VIRT
$4.95B
| $2.15M | ﹤0.01% |
85,469
-1,865
| -2% | -$43.2K |
|
639
IDEX
IEX
$17.3B
| $2.13M | ﹤0.01% |
+10,690
| New | +$2.03M |
|
640
CACI
CACI
$14.1B
| $2.12M | ﹤0.01% |
8,499
+8,205
| +2,791% | +$1.89M |
|
641
Devon Energy
DVN
$47.8B
| $2.12M | ﹤0.01% |
+133,788
| New | +$1.66M |
|
|
EXAS
642
DELISTED
Exact Sciences
EXAS
| $2.1M | ﹤0.01% |
+15,840
| New | +$1.92M |
|
|
ALXN
643
DELISTED
Alexion Pharmaceuticals
ALXN
| $2.09M | ﹤0.01% |
13,361
-184
| -1% | -$23.6K |
|
644
Matador Resources
MTDR
$6.12B
| $2.07M | ﹤0.01% |
+171,594
| New | +$1.68M |
|
645
Levi Strauss
LEVI
$9.36B
| $2.02M | ﹤0.01% |
100,400
| – | – |
|
646
KE Holdings
BEKE
$18.8B
| $2M | ﹤0.01% |
+32,441
| New | +$2.16M |
|
647
MasTec
MTZ
$21.3B
| $1.98M | ﹤0.01% |
29,073
+6,217
| +27% | +$349K |
|
648
VanEck Intermediate Muni ETF
ITM
$2.15B
| – | – |
0
| – | – |
|
649
Broadcom
AVGO
$2.02T
| $1.98M | ﹤0.01% |
45,170
| – | – |
|
|
NUVA
650
DELISTED
NuVasive, Inc.
NUVA
| $1.96M | ﹤0.01% |
34,780
+29
| +0.1% | +$1.43K |
|
Similar funds
QCM
Lazard Asset Management's Q4 2020 Portfolio in Review
As of Q4 2020, Lazard Asset Management held 2,061 positions worth $79.1B, up 11% from $71.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Lazard Asset Management withdrew a net $5.86B in Q4 2020, closing 231 positions and reducing 465 holdings. Its most notable exit was Unilever NV New York Registry Shares, an estimated $112M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Lazard Asset Management opened a new position in Sotera Health worth $100M.
- Lazard Asset Management's largest Q4 2020 buy was Sotera Health: 3,651,831 shares worth $100M.
- Lazard Asset Management added most to Sysco in Q4 2020, an estimated $273M increase.
- Lazard Asset Management's biggest Q4 2020 reduction was Pfizer, cutting an estimated $548M.
- Lazard Asset Management fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $112M.
- Lazard Asset Management's ten largest holdings make up 23% of its $79.1B portfolio in Q4 2020.
- Lazard Asset Management opened 445 new positions and closed 231 in Q4 2020.
- Lazard Asset Management's portfolio value rose 11% quarter-over-quarter to $79.1B.
Based on Lazard Asset Management's 13F filing for Q4 2020, filed 11 Feb 2021.